Artwork for Journal of Clinical Oncology

Journal of Clinical Oncology (JCO) Podcast

American Society of Clinical Oncology (ASCO)

Breast Cancer

Endometrial Cancer

Rituximab

Radiotherapy

Oncology

Genotyping

Cancer Survival Outcomes

Lung Cancer

EGFR

Adverse Events

Follicular Lymphoma

Mantle Cell Lymphoma

JCO Oncology Advances

Non-Small Cell Lung Cancer

Exercise

Prior Authorization

Personalized Medicine

Toxicity Management

Transgender Healthcare

Axillary Soft Tissue Involvement

The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO's esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice. The JCO Podcast also features in depth summaries ... more

87 ratings

Publishes	Twice monthly	Episodes	454	Founded	15 years ago
Number of Listeners		Categories	Health & FitnessMedicine

Listen to this Podcast

Guests Host Reviews Charts Talking Points

Latest Episodes

Infections in Two Diet Strategies in HSCT and Leukemia Patients

Guest Dr. John Wingard and host Dr. Davide Soldato discuss JCO article, "Randomized Non-inferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem Cell Transplant and Acute Leukemia Patients," the reason behind the tria... more

9 Apr 2026 • 20 min

JCO Article Insights: ctDNA in DLBCL - Ready for Prime Time?

In this episode of JCO Article Insights, host Dr. Ash Gurumurthi summarizes JCO articles, "Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study" a... more

30 Mar 2026 • 13 min

The CISTO Study: Radical Cystectomy or Bladder-Sparing Therapy for Recurrent NMIBC

Guest Dr. John Gore and host Dr. Davide Soldato discuss JCO article, "12-Month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent Non-Muscle Invasive Bladder Cancer," which compares radical cystecto... more

12 Mar 2026 • 19 min

JCO Article Insights: Atezolizumab, Bevacizumab, and Non-Platinum Chemotherapy for PROC

In this episode of JCO Article Insights, host Dr. Melis Canturk summarizes the article, "Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase... more

23 Feb 2026 • 6 min

Key Facts

Accepts Guests

Accepts Sponsors

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)

ASCO EducationAmerican Society of Clinical Oncology (ASCO)

Two Onc DocsSam and Karine

NEJM This WeekNEJM Group

Recent Guests

John Wingard

JCO author, Professor Emeritus

University of Florida

Episode: Infections in Two Diet Strategies in HSCT and Leukemia Patients

John Gore

JCO author, urologist at Fred Hutch Cancer Center and professor of urology at University of Washington School of Medicine

Fred Hutch Cancer Center; University of Washington

Episode: The CISTO Study: Radical Cystectomy or Bladder-Sparing Therapy for Recurrent NMIBC

Professor Andrea Necchi

Associate Professor of Medical Oncology at University San Raffaele and Medical Oncology at Ospedale San Raffaele in Milan, Italy

University San Raffaele

Episode: Milan Consensus Endpoints for Bladder Preservation in MIBC

Professor Ashish Kamat

Professor of Urology, Oncology, and Cancer Research at University of Texas MD Anderson Cancer Center

University of Texas MD Anderson Cancer Center

Episode: Milan Consensus Endpoints for Bladder Preservation in MIBC

Dr. Rusha Bhandari

Pediatric hematologist oncologist and assistant professor in the Department of Pediatrics and Population Science at City Hope

City Hope

Episode: Health Outcomes in Older Childhood Cancer Survivors

Professor Sundar Jagannath

Professor of Medicine at Icahn School of Medicine at Mount Sinai and network director for the Center of Excellence for Multiple Myeloma.

Icahn School of Medicine at Mount Sinai

Episode: Long-Term Remission After Cilta-cel in Patients With RRMM

Dr. Giancarlo Di Giuseppe

Research fellow at the Hospital for Sick Children and expert in epidemiology

Hospital for Sick Children

Episode: Income Among Adolescents and Young Adults Surviving Cancer

Hani Babikar

Associate Professor of Medicine and Consultant in Oncology

Mayo Clinic, Jacksonville

Episode: TTFields in Locally Advanced Pancreatic Adenocarcinoma

Dr. Lin

Assistant professor in the Department of Health Services Research

University of Texas MD Anderson Cancer Center

Episode: Racial and Ethnic Disparities Among Medicare Beneficiaries

Host

Dr. Davide Soldato

Host of the podcast known for his expertise in oncology and discussions with experts in the field.

Reviews

4.1 out of 5 stars from 87 ratings

Good Information, but
The information provided is important, but the presenters are stilted.
Apple Podcasts
4
Jtn2
United States10 years ago
I really want to like this podcast, but...
unfortunately, although the content is excellent, the delivery is awful. Most of the time the presenters just read the text of the podcast - very fast, in a monotonous voice. While as a written piece it could perhaps work, it doesn't work as an audio. I end up pausing and rewinding, and eventually giving up on learning and remembering. An audio lecture needs to be delivered at a slower pace, with fewer lists and numbers...
Apple Podcasts
2
Zoirusha
United States13 years ago
Nice
Good platform
Apple Podcasts
5
Gazelle73
United States15 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate the depth and relevance of the information presented, seeing it as a valuable resource for staying updated on oncology advances.

Some listeners express concerns about presentation style, indicating that while content is crucial, the delivery can feel monotonous or overly scripted. They desire a more engaging presentation to enhance understanding.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#198	Italy/Health & Fitness/Medicine
Apple Podcasts	#208	Germany/Health & Fitness/Medicine
Apple Podcasts	#16	China/Health & Fitness/Medicine
Apple Podcasts	#55	Chile/Health & Fitness/Medicine
Apple Podcasts	#122	China/Health & Fitness
Apple Podcasts	#134	South Korea/Health & Fitness/Medicine

Talking Points

Recent interactions between the hosts and their guests.

Infections in Two Diet Strategies in HSCT and Leukemia Patients

Q: What did the results suggest for clinical practice?

liberalized diet increased major infections in the studied high-risk population, supporting continued use of neutropenic diets in acute leukemia induction and stem cell transplant settings, while data are less clear for less intensively treated patients and require further study.

Infections in Two Diet Strategies in HSCT and Leukemia Patients

Q: What were the key design elements to ensure a fair comparison between diets?

The trial used a non-inferiority framework with robust infection endpoints, standardized food handling education, monitoring for adherence, inpatient oversight, and a single adjudicator applying infectious disease criteria to documented infections.

Infections in Two Diet Strategies in HSCT and Leukemia Patients

Q: What motivated testing a liberalized diet in high-risk stem cell transplant and acute leukemia patients?

Historically neutropenic diets were thought to limit infections by reducing dietary microbes, but prior trials were small, inconclusive, and often didn't measure actual infection rates or adherence; a larger, robust trial with documented infections was needed to determine true benefits or harms.

Association Between EOL SACT and Healthcare Utilization

Q: What is the relationship between systemic anticancer therapy and health outcomes at the end of life?

The research shows that systemic anticancer therapy is associated with higher healthcare utilization and adverse outcomes like increased hospitalization.

JCO at 2025 ASH: Pirtobrutinib in Untreated CLL

Q: How do you see the potential for regulatory approval for Pirtobrutinib?

Both of these trials were designed with registrational intent in the frontline setting and they're both positive studies, which is encouraging for approval.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Journal of Clinical Oncology

What is Journal of Clinical Oncology about and what kind of topics does it cover?

Focused on the latest oncology research, discussions throughout various episodes commonly revolve around new treatment protocols, clinical trials, and innovative therapies in cancer care. Episodes frequently highlight key findings from prestigious journals, including the American Society of Clinical Oncology, addressing everything from chemotherapy combinations to breakthroughs in immunotherapy and personalized medicine. What sets this resource apart is its commitment to not only delivering insights into published research but also facilitating expert discussions that bridge knowledge from academia to practical applications in clinical settings. For listeners who are deeply interested in the evolving landscape of oncology, this podcast prov... more

Where can I find podcast stats for Journal of Clinical Oncology?

Rephonic provides a wide range of podcast stats for Journal of Clinical Oncology. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Journal of Clinical Oncology and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Journal of Clinical Oncology get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Journal of Clinical Oncology, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Journal of Clinical Oncology?

Rephonic provides comprehensive predictive audience data for Journal of Clinical Oncology, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Journal of Clinical Oncology have?

To see how many followers or subscribers Journal of Clinical Oncology has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Journal of Clinical Oncology?

These podcasts share a similar audience with Journal of Clinical Oncology:

1. ASCO Daily News
2. ASCO Guidelines
3. ASCO Education
4. Two Onc Docs
5. NEJM This Week

How many episodes of Journal of Clinical Oncology are there?

Journal of Clinical Oncology launched 15 years ago and published 454 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Journal of Clinical Oncology?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Journal of Clinical Oncology?

Rephonic pulls ratings and reviews for Journal of Clinical Oncology from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Journal of Clinical Oncology?

Rephonic provides full transcripts for episodes of Journal of Clinical Oncology. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Journal of Clinical Oncology?

Recent guests on Journal of Clinical Oncology include:

1. John Wingard
2. John Gore
3. Professor Andrea Necchi
4. Professor Ashish Kamat
5. Dr. Rusha Bhandari
6. Professor Sundar Jagannath
7. Dr. Giancarlo Di Giuseppe
8. Hani Babikar

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days